{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T09:54:52Z","timestamp":1765792492629,"version":"3.48.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070189"],"award-info":[{"award-number":["32070189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272383"],"award-info":[{"award-number":["82272383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30514"],"award-info":[{"award-number":["2022JJ30514"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2021SK50302"],"award-info":[{"award-number":["2021SK50302"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijbiomac.2023.128723","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T05:35:44Z","timestamp":1702532144000},"page":"128723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["A novel chimeric recombinant FliC-Pgp3 vaccine promotes immunoprotection against Chlamydia muridarum infection in mice"],"prefix":"10.1016","volume":"258","author":[{"given":"Lanhua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglv","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"50","key":"10.1016\/j.ijbiomac.2023.128723_bb0005","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1016\/j.vaccine.2017.10.075","article-title":"National Institute of Allergy and Infectious Diseases workshop report: \u201cChlamydia vaccines: the way forward\u201d","volume":"37","author":"Zhong","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128723_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00543-16","article-title":"Update on Chlamydia trachomatis vaccinology","volume":"24","author":"de la Maza","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128723_bb0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1586\/14760584.2016.1161510","article-title":"Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis","volume":"15","author":"Yu","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128723_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41541-021-00312-9","article-title":"A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C\/C-related complex serovars","volume":"6","author":"Olsen","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.128723_bb0025","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2021.03.043","article-title":"Chlamydia trachomatis: cell biology, immunology and vaccination","volume":"39","author":"Murray","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jbiotec.2020.10.014","article-title":"Development of a high yielding bioprocess for a pre-fusion RSV subunit vaccine","volume":"325","author":"Chen","year":"2021","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128723_bb0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/CMR.00105-13","article-title":"Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research","volume":"27","author":"Vasilevsky","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128723_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.imbio.2018.11.009","article-title":"Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice","volume":"224","author":"Luan","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2180-8-90","article-title":"Antibodies from women urogenitally infected with C. Trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner","volume":"8","author":"Li","year":"2008","journal-title":"BMC Microbiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128723_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00844-18","article-title":"The plasmid-encoded pGP3 promotes Chlamydia evasion of acidic barriers in both stomach and vagina","volume":"87","author":"Zhang","year":"2019","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128723_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00472-21","article-title":"Chlamydia deficient in plasmid-encoded glycoprotein 3 (pGP3) as an attenuated live oral vaccine","volume":"90","author":"Zhou","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0060","doi-asserted-by":"crossref","first-page":"1018774","DOI":"10.3389\/fimmu.2022.1018774","article-title":"Efficacy of Pgp3 vaccination for Chlamydia urogenital tract infection depends on its native conformation","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.989620","article-title":"Chitosan particle stabilized Pickering emulsion\/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice","volume":"13","author":"Shu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0070","doi-asserted-by":"crossref","first-page":"1148253","DOI":"10.3389\/fimmu.2023.1148253","article-title":"Preparation of graphene oxide-stabilized Pickering emulsion adjuvant for Pgp3 recombinant vaccine and enhanced immunoprotection against Chlamydia trachomatis infection","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128723_bb0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41541-021-00379-4","article-title":"Deimmunization of flagellin for repeated administration as a vaccine adjuvant","volume":"6","author":"Khim","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101330","article-title":"Deimmunization of flagellin adjuvant for clinical application","volume":"60","author":"Rhee","year":"2023","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128723_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/v10030100","article-title":"DNA vaccine-encoded flagellin can be used as an adjuvant scaffold to augment HIV-1 gp41 membrane proximal external region immunogenicity","volume":"10","author":"Ajamian","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120030","article-title":"Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface","volume":"249","author":"Zhao","year":"2020","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128723_bb0095","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.4049\/jimmunol.175.12.8051","article-title":"Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells","volume":"175","author":"Crellin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621665","article-title":"Flagellin\/TLR5 stimulate myeloid progenitors to enter lung tissue and to locally differentiate into macrophages","volume":"12","author":"Lei","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128723_bb0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/acs.bioconjchem.7b00320","article-title":"Prompt and robust humoral immunity elicited by a conjugated chimeric malaria antigen with a truncated Flagellin","volume":"29","author":"Guo","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128723_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1753425912454026","article-title":"Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, \u03b1\u2212\/\u03b2-defensins and TLRs","volume":"19","author":"Hickey","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105136","article-title":"Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases","volume":"96","author":"Dorosti","year":"2021","journal-title":"Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128723_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1081328","article-title":"Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer","volume":"5","author":"Lee","year":"2016","journal-title":"Oncoimmunology"},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2023.128723_bb0125","article-title":"Panel 8: vaccines and immunology","volume":"130","author":"Alderson","year":"2020","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128723_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08830185.2018.1471479","article-title":"Developing effective vaccines: cues from natural infection","volume":"37","author":"Bhurani","year":"2018","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104272","article-title":"IFN-\u03b3(+) CD4(+)T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis","volume":"361","author":"Yadav","year":"2021","journal-title":"Cell. Immunol."},{"issue":"29","key":"10.1016\/j.ijbiomac.2023.128723_bb0140","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1016\/j.vaccine.2018.06.005","article-title":"Flagellin is a Th1 polarizing factor for human CD4(+) T cells and induces protection in a murine neonatal vaccination model of rotavirus infection","volume":"36","author":"Labastida-Conde","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0145","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3389\/fimmu.2018.01981","article-title":"An adaptive Chlamydia trachomatis-specific IFN-\u03b3-producing CD4(+) T cell response is associated with protection against Chlamydia reinfection in women","volume":"9","author":"Bakshi","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128723_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00010-17","article-title":"The predominant CD4(+) Th1 cytokine elicited to Chlamydia trachomatis infection in women is tumor necrosis factor alpha and not interferon gamma","volume":"24","author":"Jordan","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0155","first-page":"217","article-title":"Chlamydia trachomatis: protective adaptive responses and prospects for a vaccine","volume":"412","author":"Poston","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128723_bb0160","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/08820139.2021.1903033","article-title":"B Cell Response to Vaccination","volume":"50","author":"Luo","year":"2021","journal-title":"Immunol. Investig."},{"issue":"14","key":"10.1016\/j.ijbiomac.2023.128723_bb0165","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"issue":"7869","key":"10.1016\/j.ijbiomac.2023.128723_bb0170","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-021-03692-z","article-title":"Metabolic control of T(FH) cells and humoral immunity by phosphatidylethanolamine","volume":"595","author":"Fu","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128723_bb0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128723_bb0180","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41590-022-01274-3","article-title":"PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine","volume":"23","author":"Herati","year":"2022","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128723_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/v11121118","article-title":"Monophosphoryl-lipid a (MPLA) is an efficacious adjuvant for inactivated rabies vaccines","volume":"11","author":"Chen","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/JBM.S303275","article-title":"Chlamydia pneumoniae-induced IFN-gamma responses in peripheral blood mononuclear cells increase numbers of CD4+ but not CD8+ T effector memory cells","volume":"12","author":"Smith-Norowitz","year":"2021","journal-title":"Journal of Blood Medicine"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128723_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02161-21","article-title":"Enhanced cross-reactive and polyfunctional effector-memory T cell responses by ICVAX-a human PD1-based bivalent HIV-1 gag-p41 mosaic DNA vaccine","volume":"96","author":"Chen","year":"2022","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128723_bb0200","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.1700914","article-title":"A Chlamydia-specific TCR-transgenic mouse demonstrates Th1 Polyfunctionality with enhanced effector function","volume":"199","author":"Poston","year":"2017","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128723_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftab014","article-title":"T cell responses to chlamydia","volume":"79","author":"Helble","year":"2021","journal-title":"Pathogens and Disease"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128723_bb0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/icb.2015.74","article-title":"The contribution of Chlamydia-specific CD8+ T cells to upper genital tract pathology","volume":"94","author":"Vlcek","year":"2016","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128723_bb0215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4049\/jimmunol.174.3.1594","article-title":"Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection","volume":"174","author":"Martin","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128723_bb0220","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.chom.2013.10.009","article-title":"Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut","volume":"14","author":"Cullender","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"7719","key":"10.1016\/j.ijbiomac.2023.128723_bb0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-018-0395-5","article-title":"Neonatal selection by toll-like receptor 5 influences long-term gut microbiota composition","volume":"560","author":"Fulde","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128723_bb0230","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.immuni.2014.08.009","article-title":"TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination","volume":"41","author":"Oh","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128723_bb0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/mi.2017.105","article-title":"CD103(+)CD11b(+) mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin","volume":"11","author":"Flores-Langarica","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0240","doi-asserted-by":"crossref","first-page":"22040","DOI":"10.1038\/srep22040","article-title":"TLR5 mediates CD172\u03b1(+) intestinal lamina propria dendritic cell induction of Th17 cells","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.128723_bb0245","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2147\/JIR.S407521","article-title":"TLR5 signaling in the regulation of intestinal mucosal immunity","volume":"16","author":"Feng","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128723_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.gastro.2014.08.033","article-title":"Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice","volume":"147","author":"Chassaing","year":"2014","journal-title":"Gastroenterology"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023056222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023056222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T09:52:12Z","timestamp":1765792332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023056222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"alternative-id":["S0141813023056222"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128723","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel chimeric recombinant FliC-Pgp3 vaccine promotes immunoprotection against Chlamydia muridarum infection in mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"128723"}}